Detalhe da pesquisa
1.
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.
Cancer;
2024 Mar 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38470379
2.
Racial Disparities in MiT Family Translocation Renal Cell Carcinoma.
Oncologist;
28(11): 1009-1013, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37315151
3.
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas.
Oncologist;
28(5): 433-439, 2023 05 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36640141
4.
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors.
Oncologist;
27(6): 501-511, 2022 06 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35278076
5.
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
Oncologist;
27(12): 1041-1047, 2022 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35979929
6.
Renal cell carcinoma in children and adolescents: a retrospective study of a French-Italian series of 93 cases.
Histopathology;
80(6): 928-945, 2022 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35238063
7.
Addressing resistance to immune checkpoint inhibitor therapy: an urgent unmet need.
Future Oncol;
17(11): 1401-1439, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33475012
8.
Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
Oncologist;
24(7): 980-988, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30626710
9.
Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.
Histopathology;
75(6): 853-864, 2019 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31306501
10.
Should pituitary carcinoma be treated using a NET-like approach? A case of complete remission of a metastatic malignant prolactinoma with multimodal therapy including immunotherapy.
Clin Endocrinol (Oxf);
98(4): 633-637, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34845727
11.
Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas.
Histopathology;
70(7): 1089-1097, 2017 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28106924
12.
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.
BJU Int;
120(6): 782-792, 2017 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27860149
13.
Non-clear cell renal cell carcinomas: biological insights and therapeutic challenges and opportunities.
Clin Adv Hematol Oncol;
15(5): 409-418, 2017 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28591094
14.
Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.
Hepatology;
59(6): 2228-37, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24443104
15.
Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors.
Nat Commun;
14(1): 7884, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38036539
16.
An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas.
Clin Cancer Res;
29(7): 1279-1291, 2023 04 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36374555
17.
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.
Nat Commun;
14(1): 3034, 2023 05 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37236926
18.
Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma.
Cancer Res;
83(17): 2952-2969, 2023 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37335139
19.
Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas.
Cell Rep Med;
4(11): 101287, 2023 11 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37967556
20.
Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection.
Cancer;
118(20): 4981-90, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22415897